Project description
A novel assay will test an individual's rate of drug clearance to enable precise dosing
In 2018 alone, more than 100 new therapeutic drugs were approved in the EU and US. From over-the-counter treatments for headache to sophisticated targeted treatments requiring prescriptions, drugs must combine just the right synthesis of ingredients to combat what ails us. However, effective treatment relies equally on 'how much' as it does on 'what', and that varies from person to person based on a multitude of factors. One of the most important is how fast a drug is 'cleared' by the body. PreMeDosE is developing a nearly universal enzyme assay to test the activity level of the enzyme responsible for clearing most therapeutics. It will provide clinicians with critical information for truly personalised dosing.
Fields of science
Programme(s)
Funding Scheme
ERC-POC-LS - ERC Proof of Concept Lump Sum PilotHost institution
00014 Helsingin Yliopisto
Finland
See on map
Beneficiaries (1)
00014 Helsingin Yliopisto
See on map